Rewriting genetic medicine

Scribe Therapeutics is a US-based genetic medicine company that is tailoring Crispr editing technology to develop both genetic and epigenetic treatments. Founded by four scientists from the University of California, Berkely in the US – including Nobel laureate and Crispr pioneer Jennifer Doudna – the company is on a mission to ’make genetic medicine accessible to everyone’.